rs376260223
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000143.4(FH):c.1237-7C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000321 in 1,586,462 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000143.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FH | NM_000143.4 | c.1237-7C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000366560.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FH | ENST00000366560.4 | c.1237-7C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000143.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000197 AC: 25AN: 126678Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 247132Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133988
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1459652Hom.: 1 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 726212
GnomAD4 genome ? AF: 0.000197 AC: 25AN: 126810Hom.: 0 Cov.: 30 AF XY: 0.000261 AC XY: 16AN XY: 61400
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2016 | This variant is denoted FH c.1237-7C>T or IVS8-7C>T and consists of a C>T nucleotide substitution at the -7 position of intron 8 of the FH gene. Multiple splice prediction models are uninformative for this variant. In the absence of RNA or functional studies, the actual effect of this variant is unknown. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. FH c.1237-7C>T was observed with an allele frequency of 0.2% (7/4406) in African Americans in the NHLBI Exome Sequencing Project. The cytosine (C) nucleotide that is altered is not conserved across species. Based on currently available information, it is unclear whether FH c.1237-7C>T is pathogenic or benign. We consider it to be a variant of uncertain significance. - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Dec 03, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Mar 15, 2022 | - - |
FH-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 23, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at